TRICYCLIC COMPOUNDS AS SELECTIVE MUSCARINIC RECEPTOR ANTAGONISTS .3. STRUCTURE SELECTIVITY RELATIONSHIPS IN A SERIES OF CARDIOSELECTIVE (M2) ANTIMUSCARINICS

被引：47
|
作者：
ENGEL, WW
EBERLEIN, WG
MIHM, G
HAMMER, R
TRUMMLITZ, G
机构：
[1] DR KARL THOMAE GMBH,DEPT CHEM RES,D-7950 BIBERACH RISS,FED REP GER
[2] IST ANGELI SPA,DEPT BIOCHEM,MILAN,ITALY
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 1989年 / 32卷 / 08期
关键词：
D O I：
10.1021/jm00128a008
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：1718 / 1724
页数：7
相关论文
共 50 条
  • [21] Diphenylsulfone muscarinic antagonists:: Piperidine derivatives with high M2 selectivity and improved potency
    Billard, W
    Binch, H
    Bratzler, K
    Chen, LY
    Crosby, G
    Duffy, RA
    Dugar, S
    Lachowicz, J
    McQuade, R
    Pushpavanam, P
    Ruperto, VB
    Taylor, LA
    Clader, JW
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (19) : 2209 - 2212
  • [22] Structure-guided development of selective M3 muscarinic acetylcholine receptor antagonists
    Liu, Hongtao
    Hofmann, Josefa
    Fish, Inbar
    Schaake, Benjamin
    Eitel, Katrin
    Bartuschat, Amelie
    Kaindl, Jonas
    Rampp, Hannelore
    Banerjee, Ashutosh
    Huebner, Harald
    Clark, Mary J.
    Vincent, Sandra G.
    Fisher, John T.
    Heinrich, Markus R.
    Hirata, Kunio
    Liu, Xiangyu
    Sunahara, Roger K.
    Shoichet, Brian K.
    Kobilka, Brian K.
    Gmeiner, Peter
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (47) : 12046 - 12050
  • [23] Synthesis and biological evaluation of 1,2,3,4-tetrahydroisoquinoline derivatives as potent and selective M2 muscarinic receptor antagonists
    Watanabe, T
    Kinoyama, I
    Takizawa, K
    Hirano, S
    Shibanuma, T
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1999, 47 (05) : 672 - 677
  • [24] Neuromuscular relaxants as antagonists for M2 and M3 muscarinic receptors
    Hou, VY
    Hirshman, CA
    Emala, CW
    ANESTHESIOLOGY, 1998, 88 (03) : 744 - 750
  • [25] CHARACTERIZATION OF THE STRIATAL M2 MUSCARINIC RECEPTOR MEDIATING INHIBITION OF CYCLIC-AMP USING SELECTIVE ANTAGONISTS - A COMPARISON WITH THE BRAIN-STEM M2 RECEPTOR
    MCKINNEY, M
    ANDERSON, D
    FORRAY, C
    ELFAKAHANY, EE
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1989, 250 (02): : 565 - 572
  • [26] The effect of absolute configuration on activity, subtype selectivity (M3/M2) of 3α-acyloxy-6β-acetoxyltropane derivatives as muscarinic M3 receptor antagonists
    Wang, Zhi-Peng
    Liu, Hui-Zhong
    Zhu, Liang
    Hu, You-Min
    Cui, Yong-Yao
    Niu, Yin-Yao
    Lu, Yang
    Chen, Hong-Zhuan
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (05) : 1234 - 1239
  • [27] Orally active and selective benzylidene Ketal M2 muscarinic receptor antagonists for the treatment of Alzheimer's disease
    Boyle, CD
    Lachowicz, JE
    DRUG DEVELOPMENT RESEARCH, 2002, 56 (03) : 310 - 320
  • [28] Hemodynamic effects of MF 10058, a new cardioselective muscarinic M2 receptor antagonist, in conscious dogs
    Lamperti, G
    Champeroux, P
    Martel, E
    Colibretti, ML
    Santoro, L
    Imbimbo, BP
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 406 (01) : 93 - 98
  • [29] SELECTIVITY OF MUSCARINIC ANTAGONISTS IN RADIOLIGAND AND INVIVO EXPERIMENTS FOR THE PUTATIVE M1-RECEPTOR, M2-RECEPTOR AND M3-RECEPTOR
    DOODS, HN
    MATHY, MJ
    DAVIDESKO, D
    VANCHARLDORP, KJ
    DEJONGE, A
    VANZWIETEN, PA
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1987, 242 (01): : 257 - 262
  • [30] AFFINITY PROFILES OF PIZOTIFEN, KETOTIFEN AND OTHER TRICYCLIC ANTIMUSCARINICS AT MUSCARINIC RECEPTOR SUBTYPE-M1, SUBTYPE-M2 AND SUBTYPE-M3
    ELTZE, M
    MUTSCHLER, E
    LAMBRECHT, G
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 211 (03) : 283 - 293
12345